Bionano Genomics Inc (BNGO)
0.2558
-0.02
(-7.62%)
USD |
NASDAQ |
Nov 14, 16:00
0.251
0.00 (0.00%)
After-Hours: 20:00
Bionano Genomics Research and Development Expense (Quarterly): 6.831M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.831M |
| March 31, 2024 | 9.779M |
| December 31, 2023 | 11.70M |
| September 30, 2023 | 13.78M |
| June 30, 2023 | 14.61M |
| March 31, 2023 | 13.94M |
| December 31, 2022 | 14.01M |
| September 30, 2022 | 12.74M |
| June 30, 2022 | 11.77M |
| March 31, 2022 | 10.53M |
| December 31, 2021 | 9.215M |
| September 30, 2021 | 6.505M |
| June 30, 2021 | 4.086M |
| March 31, 2021 | 2.678M |
| December 31, 2020 | 2.877M |
| Date | Value |
|---|---|
| September 30, 2020 | 2.304M |
| June 30, 2020 | 2.401M |
| March 31, 2020 | 2.674M |
| December 31, 2019 | 2.399M |
| September 30, 2019 | 2.174M |
| June 30, 2019 | 2.408M |
| March 31, 2019 | 2.10M |
| December 31, 2018 | 2.522M |
| September 30, 2018 | 2.505M |
| June 30, 2018 | 2.099M |
| March 31, 2018 | 2.367M |
| December 31, 2017 | 2.458M |
| September 30, 2017 | 2.967M |
| June 30, 2017 | 3.394M |
| March 31, 2017 | 3.190M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.304M
Minimum
Sep 2020
14.61M
Maximum
Jun 2023
8.149M
Average
9.215M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
| Revvity Inc | 49.14M |
| Bruker Corp | 98.10M |
| Azenta Inc | 7.913M |
| Harvard Bioscience Inc | 2.567M |
| Akoya Biosciences Inc | 5.288M |